Longs Drug Stores (LDG) Reports Mixed Q2 Earnings

August 20, 2008 4:03 PM EDT

Longs Drug Stores Corp. (NYSE: LDG) reports Q2 EPS of $0.78, ex-items, 2 cents better than the analyst estimate of $0.76. Revenues for the quarter were $1.33 billion, versus the consensus of $1.35 billion.

Notably, the company is being acquired by CVS/Caremark (NYSE: CVS).

Longs Drug Stores Corporation operates retail drug stores and provides pharmacy benefit management services in the United States.


Related Categories

Earnings

Stocks Mentioned

CVS 27.08

+0.01 +0.04%
Volume: 10,318,171
Track CVS

LDG 71.51

+0.00 +0.00%
Volume: 1,136,529
Track LDG


Add Your Comment